Matches in SemOpenAlex for { <https://semopenalex.org/work/W2601688508> ?p ?o ?g. }
- W2601688508 endingPage "31" @default.
- W2601688508 startingPage "31" @default.
- W2601688508 abstract "By physically interacting with beta-1 integrins, the NG2 proteoglycan enhances activation of the integrin heterodimers. In glioma cells, co-localization of NG2 and 31 integrin in individual cells (cis interaction) can be demonstrated by immunolabeling, and the NG2-integrin interaction can be confirmed by co-immunoprecipitation. NG2-dependent integrin activation is detected via use of conformationally sensitive monoclonal antibodies that reveal the activated state of the beta-1 subunit in NG2-positive versus NG2-negative cells. NG2-dependent activation of beta-1 integrins triggers downstream activation of FAK and PI3K/Akt signaling, resulting in increased glioma cell proliferation, motility, and survival. Similar NG2-dependent cis activation of beta-1 integrins occurs in microvascular pericytes, leading to enhanced proliferation and motility of these vascular cells. Surprisingly, pericyte NG2 is also able to promote beta-1 integrin activation in closely apposed endothelial cells (trans interaction). Enhanced beta-1 signaling in endothelial cells promotes endothelial maturation by inducing the formation of endothelial junctions, resulting in increased barrier function of the endothelium and increased basal lamina assembly. NG2-dependent beta-1 integrin signaling is therefore important for tumor progression by virtue of its affects not only on the tumor cells themselves, but also on the maturation and function of tumor blood vessels." @default.
- W2601688508 created "2017-04-07" @default.
- W2601688508 creator A5054579830 @default.
- W2601688508 date "2017-03-31" @default.
- W2601688508 modified "2023-09-23" @default.
- W2601688508 title "NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations" @default.
- W2601688508 cites W1564633285 @default.
- W2601688508 cites W1581438182 @default.
- W2601688508 cites W1595293335 @default.
- W2601688508 cites W1846608835 @default.
- W2601688508 cites W185147093 @default.
- W2601688508 cites W1877728416 @default.
- W2601688508 cites W1976419559 @default.
- W2601688508 cites W1977657343 @default.
- W2601688508 cites W1983967012 @default.
- W2601688508 cites W1985804036 @default.
- W2601688508 cites W1995646379 @default.
- W2601688508 cites W1997584084 @default.
- W2601688508 cites W1998967221 @default.
- W2601688508 cites W1999140776 @default.
- W2601688508 cites W2001186215 @default.
- W2601688508 cites W2004106061 @default.
- W2601688508 cites W2004471993 @default.
- W2601688508 cites W2008449035 @default.
- W2601688508 cites W2010974685 @default.
- W2601688508 cites W2012371827 @default.
- W2601688508 cites W2018516857 @default.
- W2601688508 cites W2019341013 @default.
- W2601688508 cites W2024599421 @default.
- W2601688508 cites W2025134405 @default.
- W2601688508 cites W2031989668 @default.
- W2601688508 cites W2033545273 @default.
- W2601688508 cites W2033768992 @default.
- W2601688508 cites W2048482524 @default.
- W2601688508 cites W2049385358 @default.
- W2601688508 cites W2050106278 @default.
- W2601688508 cites W2054243450 @default.
- W2601688508 cites W2062762606 @default.
- W2601688508 cites W2065599791 @default.
- W2601688508 cites W2069033214 @default.
- W2601688508 cites W2080170002 @default.
- W2601688508 cites W2082864993 @default.
- W2601688508 cites W2083771712 @default.
- W2601688508 cites W2087774979 @default.
- W2601688508 cites W2088813072 @default.
- W2601688508 cites W2089929639 @default.
- W2601688508 cites W2094935740 @default.
- W2601688508 cites W2097465856 @default.
- W2601688508 cites W2103951942 @default.
- W2601688508 cites W2106187425 @default.
- W2601688508 cites W2106210309 @default.
- W2601688508 cites W2112328123 @default.
- W2601688508 cites W2115390024 @default.
- W2601688508 cites W2115828984 @default.
- W2601688508 cites W2117910176 @default.
- W2601688508 cites W2119836524 @default.
- W2601688508 cites W2120621109 @default.
- W2601688508 cites W2120682723 @default.
- W2601688508 cites W2121681121 @default.
- W2601688508 cites W2130037917 @default.
- W2601688508 cites W2130101439 @default.
- W2601688508 cites W2133671516 @default.
- W2601688508 cites W2134792095 @default.
- W2601688508 cites W2135627690 @default.
- W2601688508 cites W2139144917 @default.
- W2601688508 cites W2144137250 @default.
- W2601688508 cites W2145604739 @default.
- W2601688508 cites W2147233186 @default.
- W2601688508 cites W2153868039 @default.
- W2601688508 cites W2168480575 @default.
- W2601688508 cites W2169122887 @default.
- W2601688508 cites W2183578062 @default.
- W2601688508 cites W2239688246 @default.
- W2601688508 cites W2275632245 @default.
- W2601688508 cites W2289064841 @default.
- W2601688508 cites W2312610180 @default.
- W2601688508 cites W2397945685 @default.
- W2601688508 cites W2520633772 @default.
- W2601688508 cites W2522355464 @default.
- W2601688508 cites W2531599784 @default.
- W2601688508 cites W2584924004 @default.
- W2601688508 cites W2804842145 @default.
- W2601688508 cites W91126227 @default.
- W2601688508 doi "https://doi.org/10.3390/cancers9040031" @default.
- W2601688508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5406706" @default.
- W2601688508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28362324" @default.
- W2601688508 hasPublicationYear "2017" @default.
- W2601688508 type Work @default.
- W2601688508 sameAs 2601688508 @default.
- W2601688508 citedByCount "28" @default.
- W2601688508 countsByYear W26016885082017 @default.
- W2601688508 countsByYear W26016885082018 @default.
- W2601688508 countsByYear W26016885082019 @default.
- W2601688508 countsByYear W26016885082020 @default.
- W2601688508 countsByYear W26016885082021 @default.
- W2601688508 countsByYear W26016885082022 @default.
- W2601688508 countsByYear W26016885082023 @default.
- W2601688508 crossrefType "journal-article" @default.